CHAPEL HILL, N.C.--(BUSINESS WIRE)--Sept. 8, 2004--POZEN Inc.
(NASDAQ: POZN) announced today that the Company will be speaking to
investors at the Bear Stearns 17th Annual HealthCare Conference on
Tuesday, September 14, at 4:15 p.m. Eastern Time in New York. The
company presentation will be webcast live and archived on POZEN's home
page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. Since its
inception, POZEN has focused its efforts primarily on the development
of pharmaceutical products for the treatment of migraine. POZEN has
development and commercial alliances with GlaxoSmithKline, Xcel
Pharmaceuticals, and Nycomed. The company's common stock is traded on
The Nasdaq Stock Market under the symbol "POZN". For detailed company
information, including copies of this and other press releases, see
POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Bill Hodges, Chief Financial Officer, 919-913-1030
John Barnhardt, Vice President, Finance and
SOURCE: Pozen Inc.